-
1
-
-
85013059565
-
ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Pathology: Diagnosis and prognostic stratification
-
Perren, A. et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology: diagnosis and prognostic stratification. Neuroendocrinology http://dx.doi.org/10.1159/000457956 (2017).
-
(2017)
Neuroendocrinology
-
-
Perren, A.1
-
2
-
-
37649022748
-
Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified?
-
Ferrone, C.R. et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J. Clin. Oncol. 25, 5609-5615 (2007).
-
(2007)
J. Clin. Oncol.
, vol.25
, pp. 5609-5615
-
-
Ferrone, C.R.1
-
3
-
-
0036605747
-
Prognostic factors in pancreatic endocrine neoplasms: An analysis of 136 cases with a proposal for low-grade and intermediate-grade groups
-
Hochwald, S.N. et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J. Clin. Oncol. 20, 2633-2642 (2002).
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 2633-2642
-
-
Hochwald, S.N.1
-
4
-
-
84880150788
-
Comparison of WHO classifications (2004, 2010), the hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors
-
Liu, T.C., Hamilton, N., Hawkins, W., Gao, F. & Cao, D. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors. Am. J. Surg. Pathol. 37, 853-859 (2013).
-
(2013)
Am. J. Surg. Pathol.
, vol.37
, pp. 853-859
-
-
Liu, T.C.1
Hamilton, N.2
Hawkins, W.3
Gao, F.4
Cao, D.5
-
5
-
-
84964476030
-
Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: A pathway distinct from poorly differentiated neuroendocrine carcinomas
-
Tang, L.H. et al. Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas. Clin. Cancer Res. 22, 1011-1017 (2016).
-
(2016)
Clin. Cancer Res.
, vol.22
, pp. 1011-1017
-
-
Tang, L.H.1
-
6
-
-
84884979038
-
Neuroendocrine tumours-challenges in the diagnosis and classification of pulmonary neuroendocrine tumours
-
den Bakker, M.A. & Thunnissen, F.B. Neuroendocrine tumours-challenges in the diagnosis and classification of pulmonary neuroendocrine tumours. J. Clin. Pathol. 66, 862-869 (2013).
-
(2013)
J. Clin. Pathol.
, vol.66
, pp. 862-869
-
-
Den Bakker, M.A.1
Thunnissen, F.B.2
-
7
-
-
84911929619
-
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
-
Janson, E.T. et al. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncol. 53, 1284-1297 (2014).
-
(2014)
Acta Oncol.
, vol.53
, pp. 1284-1297
-
-
Janson, E.T.1
-
8
-
-
84976285439
-
Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms
-
Kidd, M., Modlin, I. & Öberg, K. Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms. Nat. Rev. Clin. Oncol. 13, 691-705 (2016).
-
(2016)
Nat. Rev. Clin. Oncol.
, vol.13
, pp. 691-705
-
-
Kidd, M.1
Modlin, I.2
Öberg, K.3
-
9
-
-
84958761514
-
Neuroendocrine tumors of the prostate: Emerging insights from molecular data and updates to the 2016 world health organization classification
-
Priemer, D.S. et al. Neuroendocrine tumors of the prostate: emerging insights from molecular data and updates to the 2016 World Health Organization classification. Endocr. Pathol. 27, 123-135 (2016).
-
(2016)
Endocr. Pathol.
, vol.27
, pp. 123-135
-
-
Priemer, D.S.1
-
10
-
-
84900298433
-
Neuroendocrine tumors of the pancreas: Current concepts and controversies
-
Reid, M.D., Balci, S., Saka, B. & Adsay, N.V. Neuroendocrine tumors of the pancreas: current concepts and controversies. Endocr. Pathol. 25, 65-79 (2014).
-
(2014)
Endocr. Pathol.
, vol.25
, pp. 65-79
-
-
Reid, M.D.1
Balci, S.2
Saka, B.3
Adsay, N.V.4
-
11
-
-
84885938243
-
Neuroendocrine tumors of the gynecologic tract: Select topics
-
Rouzbahman, M. & Clarke, B. Neuroendocrine tumors of the gynecologic tract: select topics. Semin. Diagn. Pathol. 30, 224-233 (2013).
-
(2013)
Semin. Diagn. Pathol.
, vol.30
, pp. 224-233
-
-
Rouzbahman, M.1
Clarke, B.2
-
12
-
-
85014580625
-
Whole-genome landscape of pancreatic neuroendocrine tumours
-
Scarpa, A. et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 543, 65-71 (2017).
-
(2017)
Nature
, vol.543
, pp. 65-71
-
-
Scarpa, A.1
-
13
-
-
85009505564
-
MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition
-
Mollaoglu, G. et al. MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition. Cancer Cell 31, 270-285 (2017).
-
(2017)
Cancer Cell
, vol.31
, pp. 270-285
-
-
Mollaoglu, G.1
-
14
-
-
84938132350
-
Comprehensive genomic profiles of small cell lung cancer
-
George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47-53 (2015).
-
(2015)
Nature
, vol.524
, pp. 47-53
-
-
George, J.1
-
15
-
-
84902284546
-
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
-
Fernandez-Cuesta, L. et al. Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nat. Commun. 5, 3518 (2014).
-
(2014)
Nat. Commun.
, vol.5
, pp. 3518
-
-
Fernandez-Cuesta, L.1
-
16
-
-
84978505017
-
Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets
-
Rekhtman, N. et al. Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets. Clin. Cancer Res. 22, 3618-3629 (2016).
-
(2016)
Clin. Cancer Res.
, vol.22
, pp. 3618-3629
-
-
Rekhtman, N.1
-
17
-
-
84866851740
-
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
-
Peifer, M. et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet. 44, 1104-1110 (2012).
-
(2012)
Nat. Genet.
, vol.44
, pp. 1104-1110
-
-
Peifer, M.1
-
18
-
-
84957623685
-
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
-
Beltran, H. et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat. Med. 22, 298-305 (2016).
-
(2016)
Nat. Med.
, vol.22
, pp. 298-305
-
-
Beltran, H.1
-
19
-
-
84905029258
-
Comprehensive molecular profiling of lung adenocarcinoma
-
Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543-550 (2014).
-
(2014)
Nature
, vol.511
, pp. 543-550
-
-
-
20
-
-
54549094903
-
Somatic mutations affect key pathways in lung adenocarcinoma
-
Ding, L. et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075 (2008).
-
(2008)
Nature
, vol.455
, pp. 1069-1075
-
-
Ding, L.1
-
21
-
-
84866410479
-
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
-
Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107-1120 (2012).
-
(2012)
Cell
, vol.150
, pp. 1107-1120
-
-
Imielinski, M.1
-
22
-
-
84928761118
-
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
-
Rizvi, N.A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124-128 (2015).
-
(2015)
Science
, vol.348
, pp. 124-128
-
-
Rizvi, N.A.1
-
23
-
-
84896715260
-
Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma
-
Tan, H.L. et al. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin. Cancer Res. 20, 890-903 (2014).
-
(2014)
Clin. Cancer Res.
, vol.20
, pp. 890-903
-
-
Tan, H.L.1
-
24
-
-
39749113080
-
Clonal integration of a polyomavirus in human merkel cell carcinoma
-
Feng, H., Shuda, M., Chang, Y. & Moore, P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319, 1096-1100 (2008).
-
(2008)
Science
, vol.319
, pp. 1096-1100
-
-
Feng, H.1
Shuda, M.2
Chang, Y.3
Moore, P.S.4
-
26
-
-
33748078111
-
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
-
Zhou, Z. et al. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res. 66, 7889-7898 (2006).
-
(2006)
Cancer Res.
, vol.66
, pp. 7889-7898
-
-
Zhou, Z.1
-
27
-
-
0002221849
-
Neuroblastoma
-
(eds. Pizzo, P.A. & Poplack, D.G.) (J.B. Lippincott Co., Philadelphia, PA)
-
Brodeur, G.M. & Castleberry, R.G. Neuroblastoma. in Principles and Practice of Pediatric Oncology (eds. Pizzo, P.A. & Poplack, D.G.) 739-767 (J.B. Lippincott Co., Philadelphia, PA, 1993).
-
(1993)
Principles and Practice of Pediatric Oncology
, pp. 739-767
-
-
Brodeur, G.M.1
Castleberry, R.G.2
-
28
-
-
84953320759
-
Merkel cell polyomavirus small T antigen induces cancer and embryonic merkel cell proliferation in a transgenic mouse model
-
Shuda, M. et al. Merkel cell polyomavirus small T antigen induces cancer and embryonic merkel cell proliferation in a transgenic mouse model. PLoS One 10, e0142329 (2015).
-
(2015)
PLoS One
, vol.10
, pp. e0142329
-
-
Shuda, M.1
-
29
-
-
84928976319
-
Tumorigenic activity of merkel cell polyomavirus T antigens expressed in the stratified epithelium of mice
-
Spurgeon, M.E., Cheng, J., Bronson, R.T., Lambert, P.F. & DeCaprio, J.A. Tumorigenic activity of merkel cell polyomavirus T antigens expressed in the stratified epithelium of mice. Cancer Res. 75, 1068-1079 (2015).
-
(2015)
Cancer Res.
, vol.75
, pp. 1068-1079
-
-
Spurgeon, M.E.1
Cheng, J.2
Bronson, R.T.3
Lambert, P.F.4
DeCaprio, J.A.5
-
30
-
-
84928389520
-
Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice
-
Verhaegen, M.E. et al. Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice. J. Invest. Dermatol. 135, 1415-1424 (2015).
-
(2015)
J. Invest. Dermatol.
, vol.135
, pp. 1415-1424
-
-
Verhaegen, M.E.1
-
31
-
-
0034945537
-
N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling
-
Cavallaro, U., Niedermeyer, J., Fuxa, M. & Christofori, G. N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat. Cell Biol. 3, 650-657 (2001).
-
(2001)
Nat. Cell Biol.
, vol.3
, pp. 650-657
-
-
Cavallaro, U.1
Niedermeyer, J.2
Fuxa, M.3
Christofori, G.4
-
32
-
-
84900437332
-
PTEN is a potent suppressor of small cell lung cancer
-
Cui, M. et al. PTEN is a potent suppressor of small cell lung cancer. Mol. Cancer Res. 12, 654-659 (2014).
-
(2014)
Mol. Cancer Res.
, vol.12
, pp. 654-659
-
-
Cui, M.1
-
33
-
-
0033181989
-
The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer
-
Kobayashi, S., Okada, S., Hasumi, T., Sato, N. & Fujimura, S. The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer. Tohoku J. Exp. Med. 189, 37-49 (1999).
-
(1999)
Tohoku J. Exp. Med.
, vol.189
, pp. 37-49
-
-
Kobayashi, S.1
Okada, S.2
Hasumi, T.3
Sato, N.4
Fujimura, S.5
-
34
-
-
84896333670
-
Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing
-
McFadden, D.G. et al. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell 156, 1298-1311 (2014).
-
(2014)
Cell
, vol.156
, pp. 1298-1311
-
-
McFadden, D.G.1
-
35
-
-
0141523025
-
Induction of small cell lung cancer by somatic inactivation of both trp53 and Rb1 in a conditional mouse model
-
Meuwissen, R. et al. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4, 181-189 (2003).
-
(2003)
Cancer Cell
, vol.4
, pp. 181-189
-
-
Meuwissen, R.1
-
36
-
-
77952794331
-
Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma
-
Schaffer, B.E. et al. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res. 70, 3877-3883 (2010).
-
(2010)
Cancer Res.
, vol.70
, pp. 3877-3883
-
-
Schaffer, B.E.1
-
37
-
-
0035103446
-
Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)
-
Shibayama, T. et al. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Lung Cancer 32, 61-69 (2001).
-
(2001)
Lung Cancer
, vol.32
, pp. 61-69
-
-
Shibayama, T.1
-
38
-
-
84989936333
-
ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs
-
Borromeo, M.D. et al. ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs. Cell Rep. 16, 1259-1272 (2016).
-
(2016)
Cell Rep.
, vol.16
, pp. 1259-1272
-
-
Borromeo, M.D.1
-
39
-
-
84929949436
-
The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung
-
Gazdar, A.F. et al. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J. Thorac. Oncol. 10, 553-564 (2015).
-
(2015)
J. Thorac. Oncol.
, vol.10
, pp. 553-564
-
-
Gazdar, A.F.1
-
40
-
-
0023731010
-
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
-
DeCaprio, J.A. et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54, 275-283 (1988).
-
(1988)
Cell
, vol.54
, pp. 275-283
-
-
DeCaprio, J.A.1
-
41
-
-
0018348655
-
T antigen is bound to a host protein in SV40-transformed cells
-
Lane, D.P. & Crawford, L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature 278, 261-263 (1979).
-
(1979)
Nature
, vol.278
, pp. 261-263
-
-
Lane, D.P.1
Crawford, L.V.2
-
42
-
-
0018760324
-
Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
-
Linzer, D.I. & Levine, A.J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17, 43-52 (1979).
-
(1979)
Cell
, vol.17
, pp. 43-52
-
-
Linzer, D.I.1
Levine, A.J.2
-
43
-
-
0033049122
-
Pathologic progression of autochthonous prostate cancer in the TRAMP model
-
Gingrich, J.R., Barrios, R.J., Foster, B.A. & Greenberg, N.M. Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis. 2, 70-75 (1999).
-
(1999)
Prostate Cancer Prostatic Dis.
, vol.2
, pp. 70-75
-
-
Gingrich, J.R.1
Barrios, R.J.2
Foster, B.A.3
Greenberg, N.M.4
-
44
-
-
0029832290
-
Metastatic prostate cancer in a transgenic mouse
-
Gingrich, J.R. et al. Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56, 4096-4102 (1996).
-
(1996)
Cancer Res.
, vol.56
, pp. 4096-4102
-
-
Gingrich, J.R.1
-
45
-
-
0028911462
-
Prostate cancer in a transgenic mouse
-
Greenberg, N.M. et al. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 92, 3439-3443 (1995).
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 3439-3443
-
-
Greenberg, N.M.1
-
46
-
-
0038415024
-
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model
-
Kaplan-Lefko, P.J. et al. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55, 219-237 (2003).
-
(2003)
Prostate
, vol.55
, pp. 219-237
-
-
Kaplan-Lefko, P.J.1
-
47
-
-
14944360231
-
Knockin of SV40 tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model
-
Duan, W. et al. Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model. Oncogene 24, 1510-1524 (2005).
-
(2005)
Oncogene
, vol.24
, pp. 1510-1524
-
-
Duan, W.1
-
48
-
-
14044265765
-
A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies
-
Gabril, M.Y. et al. A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies. Mol. Ther. 11, 348-362 (2005).
-
(2005)
Mol. Ther.
, vol.11
, pp. 348-362
-
-
Gabril, M.Y.1
-
49
-
-
0036892926
-
Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model
-
Gabril, M.Y. et al. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model. Gene Ther. 9, 1589-1599 (2002).
-
(2002)
Gene Ther.
, vol.9
, pp. 1589-1599
-
-
Gabril, M.Y.1
-
50
-
-
0032446247
-
A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells
-
Garabedian, E.M., Humphrey, P.A. & Gordon, J.I. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proc. Natl. Acad. Sci. USA 95, 15382-15387 (1998).
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 15382-15387
-
-
Garabedian, E.M.1
Humphrey, P.A.2
Gordon, J.I.3
-
51
-
-
5144225237
-
Hepsin promotes prostate cancer progression and metastasis
-
Klezovitch, O. et al. Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6, 185-195 (2004).
-
(2004)
Cancer Cell
, vol.6
, pp. 185-195
-
-
Klezovitch, O.1
-
52
-
-
0035949707
-
Haploinsufficiency of the pten tumor suppressor gene promotes prostate cancer progression
-
Kwabi-Addo, B. et al. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc. Natl. Acad. Sci. USA 98, 11563-11568 (2001).
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 11563-11568
-
-
Kwabi-Addo, B.1
-
53
-
-
0035266381
-
A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential
-
Masumori, N. et al. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res. 61, 2239-2249 (2001).
-
(2001)
Cancer Res.
, vol.61
, pp. 2239-2249
-
-
Masumori, N.1
-
54
-
-
0030071527
-
Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice
-
Perez-Stable, C. et al. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice. Lab. Invest. 74, 363-373 (1996).
-
(1996)
Lab. Invest.
, vol.74
, pp. 363-373
-
-
Perez-Stable, C.1
-
55
-
-
84924650706
-
Extra-prostatic transgene-associated neoplastic lesions in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice
-
Berman-Booty, L.D. et al. Extra-prostatic transgene-associated neoplastic lesions in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice. Toxicol. Pathol. 43, 186-197 (2015).
-
(2015)
Toxicol. Pathol.
, vol.43
, pp. 186-197
-
-
Berman-Booty, L.D.1
-
56
-
-
18244379285
-
An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse
-
Suttie, A.W. et al. An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse. Toxicol. Pathol. 33, 386-397 (2005).
-
(2005)
Toxicol. Pathol.
, vol.33
, pp. 386-397
-
-
Suttie, A.W.1
-
57
-
-
18944363107
-
Epithelial-stromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model
-
Tani, Y., Suttie, A., Flake, G.P., Nyska, A. & Maronpot, R.R. Epithelial-stromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model. Vet. Pathol. 42, 306-314 (2005).
-
(2005)
Vet. Pathol.
, vol.42
, pp. 306-314
-
-
Tani, Y.1
Suttie, A.2
Flake, G.P.3
Nyska, A.4
Maronpot, R.R.5
-
58
-
-
85009286726
-
Rb1 and trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
-
Ku, S.Y. et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science 355, 78-83 (2017).
-
(2017)
Science
, vol.355
, pp. 78-83
-
-
Ku, S.Y.1
-
59
-
-
80052461278
-
Prostate epithelial pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition
-
Martin, P. et al. Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. Am. J. Pathol. 179, 422-435 (2011).
-
(2011)
Am. J. Pathol.
, vol.179
, pp. 422-435
-
-
Martin, P.1
-
60
-
-
85009250505
-
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer
-
Mu, P. et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 355, 84-88 (2017).
-
(2017)
Science
, vol.355
, pp. 84-88
-
-
Mu, P.1
-
61
-
-
0037366067
-
Neuroblastoma: Biological insights into a clinical enigma
-
Brodeur, G.M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3, 203-216 (2003).
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 203-216
-
-
Brodeur, G.M.1
-
62
-
-
0021261878
-
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
-
Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. & Bishop, J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121-1124 (1984).
-
(1984)
Science
, vol.224
, pp. 1121-1124
-
-
Brodeur, G.M.1
Seeger, R.C.2
Schwab, M.3
Varmus, H.E.4
Bishop, J.M.5
-
63
-
-
0021705664
-
Activated expression of the N-myc gene in human neuroblastomas and related tumors
-
Kohl, N.E., Gee, C.E. & Alt, F.W. Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science 226, 1335-1337 (1984).
-
(1984)
Science
, vol.226
, pp. 1335-1337
-
-
Kohl, N.E.1
Gee, C.E.2
Alt, F.W.3
-
64
-
-
84933040610
-
A cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
-
Althoff, K. et al. A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. Oncogene 34, 3357-3368 (2015).
-
(2015)
Oncogene
, vol.34
, pp. 3357-3368
-
-
Althoff, K.1
-
65
-
-
0026541828
-
5′ flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice
-
Banerjee, S.A., Hoppe, P., Brilliant, M. & Chikaraishi, D.M. 5′ flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice. J. Neurosci. 12, 4460-4467 (1992).
-
(1992)
J. Neurosci.
, vol.12
, pp. 4460-4467
-
-
Banerjee, S.A.1
Hoppe, P.2
Brilliant, M.3
Chikaraishi, D.M.4
-
66
-
-
0026236567
-
Deletions and rearrangements of the retinoblastoma gene in hepatocellular carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors
-
Nakamura, T. et al. Deletions and rearrangements of the retinoblastoma gene in hepatocellular carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors. Jpn. J. Clin. Oncol. 21, 325-329 (1991).
-
(1991)
Jpn. J. Clin. Oncol.
, vol.21
, pp. 325-329
-
-
Nakamura, T.1
-
67
-
-
0027439597
-
Neurofibromatosis type 1 gene mutations in neuroblastoma
-
The, I. et al. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat. Genet. 3, 62-66 (1993).
-
(1993)
Nat. Genet.
, vol.3
, pp. 62-66
-
-
The, I.1
-
68
-
-
0030999641
-
Targeted expression of MYCN causes neuroblastoma in transgenic mice
-
Weiss, W.A., Aldape, K., Mohapatra, G., Feuerstein, B.G. & Bishop, J.M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16, 2985-2995 (1997).
-
(1997)
EMBO J.
, vol.16
, pp. 2985-2995
-
-
Weiss, W.A.1
Aldape, K.2
Mohapatra, G.3
Feuerstein, B.G.4
Bishop, J.M.5
-
69
-
-
84978664408
-
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
-
Powers, J.T. et al. Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. Nature 535, 246-251 (2016).
-
(2016)
Nature
, vol.535
, pp. 246-251
-
-
Powers, J.T.1
-
70
-
-
84991790827
-
N-myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer
-
Dardenne, E. et al. N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer. Cancer Cell 30, 563-577 (2016).
-
(2016)
Cancer Cell
, vol.30
, pp. 563-577
-
-
Dardenne, E.1
-
71
-
-
84962090106
-
N-myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells
-
Lee, J.K. et al. N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells. Cancer Cell 29, 536-547 (2016).
-
(2016)
Cancer Cell
, vol.29
, pp. 536-547
-
-
Lee, J.K.1
-
72
-
-
84893809132
-
Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells
-
Huijbers, I.J. et al. Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells. EMBO Mol. Med. 6, 212-225 (2014).
-
(2014)
EMBO Mol. Med.
, vol.6
, pp. 212-225
-
-
Huijbers, I.J.1
-
73
-
-
84895808107
-
MYC, MAX, and small cell lung cancer
-
Rudin, C.M. & Poirier, J.T. MYC, MAX, and small cell lung cancer. Cancer Discov. 4, 273-274 (2014).
-
(2014)
Cancer Discov.
, vol.4
, pp. 273-274
-
-
Rudin, C.M.1
Poirier, J.T.2
-
74
-
-
84867627577
-
A framework for identification of actionable cancer genome dependencies in small cell lung cancer
-
Sos, M.L. et al. A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proc. Natl. Acad. Sci. USA 109, 17034-17039 (2012).
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 17034-17039
-
-
Sos, M.L.1
-
75
-
-
84892369037
-
Targets in small cell lung cancer
-
Teicher, B.A. Targets in small cell lung cancer. Biochem. Pharmacol. 87, 211-219 (2014).
-
(2014)
Biochem. Pharmacol.
, vol.87
, pp. 211-219
-
-
Teicher, B.A.1
-
76
-
-
0034910622
-
Molecular genetics of small cell lung carcinoma
-
Wistuba, I.I., Gazdar, A.F. & Minna, J.D. Molecular genetics of small cell lung carcinoma. Semin. Oncol. 28 (Suppl. 4), 3-13 (2001).
-
(2001)
Semin. Oncol.
, vol.28
, pp. 3-13
-
-
Wistuba, I.I.1
Gazdar, A.F.2
Minna, J.D.3
-
77
-
-
84974605091
-
Genetic requirement for mycl and efficacy of RNA pol I inhibition in mouse models of small cell lung cancer
-
Kim, D.W. et al. Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer. Genes Dev. 30, 1289-1299 (2016).
-
(2016)
Genes Dev.
, vol.30
, pp. 1289-1299
-
-
Kim, D.W.1
-
78
-
-
84888643233
-
Development and characteristics of preclinical experimental models for the research of rare neuroendocrine bladder cancer
-
Hofner, T. et al. Development and characteristics of preclinical experimental models for the research of rare neuroendocrine bladder cancer. J. Urol. 190, 2263-2270 (2013).
-
(2013)
J. Urol.
, vol.190
, pp. 2263-2270
-
-
Hofner, T.1
-
79
-
-
3142619403
-
The sema domain of met is necessary for receptor dimerization and activation
-
Kong-Beltran, M., Stamos, J. & Wickramasinghe, D. The Sema domain of Met is necessary for receptor dimerization and activation. Cancer Cell 6, 75-84 (2004).
-
(2004)
Cancer Cell
, vol.6
, pp. 75-84
-
-
Kong-Beltran, M.1
Stamos, J.2
Wickramasinghe, D.3
-
80
-
-
84866324536
-
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1
-
Byers, L.A. et al. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov. 2, 798-811 (2012).
-
(2012)
Cancer Discov.
, vol.2
, pp. 798-811
-
-
Byers, L.A.1
-
81
-
-
84872732113
-
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases
-
Aryee, M.J. et al. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci. Transl. Med. 5, 169ra10 (2013).
-
(2013)
Sci. Transl. Med.
, vol.5
, pp. 169ra10
-
-
Aryee, M.J.1
-
82
-
-
84860168795
-
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
-
Beltran, H. et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov. 1, 487-495 (2011).
-
(2011)
Cancer Discov.
, vol.1
, pp. 487-495
-
-
Beltran, H.1
-
83
-
-
84899635480
-
Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
-
Jelinic, P. et al. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat. Genet. 46, 424-426 (2014).
-
(2014)
Nat. Genet.
, vol.46
, pp. 424-426
-
-
Jelinic, P.1
-
84
-
-
84899635792
-
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
-
Ramos, P. et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat. Genet. 46, 427-429 (2014).
-
(2014)
Nat. Genet.
, vol.46
, pp. 427-429
-
-
Ramos, P.1
-
85
-
-
84948570001
-
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
-
Poirier, J.T. et al. DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2. Oncogene 34, 5869-5878 (2015).
-
(2015)
Oncogene
, vol.34
, pp. 5869-5878
-
-
Poirier, J.T.1
-
86
-
-
0014510423
-
The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept
-
Pearse, A.G. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J. Histochem. Cytochem. 17, 303-313 (1969).
-
(1969)
J. Histochem. Cytochem.
, vol.17
, pp. 303-313
-
-
Pearse, A.G.1
-
87
-
-
0017625081
-
Analysis of endoderm formation in the avian blastoderm by the use of quail-chick chimaeras. The problem of the neurectodermal origin of the cells of the APUD series
-
Fontaine, J. & Le Douarin, N.M. Analysis of endoderm formation in the avian blastoderm by the use of quail-chick chimaeras. The problem of the neurectodermal origin of the cells of the APUD series. J. Embryol. Exp. Morphol. 41, 209-222 (1977).
-
(1977)
J. Embryol. Exp. Morphol.
, vol.41
, pp. 209-222
-
-
Fontaine, J.1
Le Douarin, N.M.2
-
88
-
-
79953306029
-
The origin of neuroendocrine tumors and the neural crest saga
-
Rosai, J. The origin of neuroendocrine tumors and the neural crest saga. Mod. Pathol. 24 (Suppl. 2), S53-S57 (2011).
-
(2011)
Mod. Pathol.
, vol.24
, pp. S53-S57
-
-
Rosai, J.1
-
89
-
-
84857714411
-
Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors
-
Yachida, S. et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am. J. Surg. Pathol. 36, 173-184 (2012).
-
(2012)
Am. J. Surg. Pathol.
, vol.36
, pp. 173-184
-
-
Yachida, S.1
-
90
-
-
33846579213
-
Small cell carcinomas of the gastrointestinal tract: Clinicopathological features and treatment approach
-
Brenner, B., Tang, L.H., Shia, J., Klimstra, D.S. & Kelsen, D.P. Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Semin. Oncol. 34, 43-50 (2007).
-
(2007)
Semin. Oncol.
, vol.34
, pp. 43-50
-
-
Brenner, B.1
Tang, L.H.2
Shia, J.3
Klimstra, D.S.4
Kelsen, D.P.5
-
91
-
-
42649089083
-
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
-
Shia, J. et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am. J. Surg. Pathol. 32, 719-731 (2008).
-
(2008)
Am. J. Surg. Pathol.
, vol.32
, pp. 719-731
-
-
Shia, J.1
-
92
-
-
84934292801
-
Transformation from non-small-cell lung cancer to small-cell lung cancer: Molecular drivers and cells of origin
-
Oser, M.G., Niederst, M.J., Sequist, L.V. & Engelman, J.A. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 16, e165-e172 (2015).
-
(2015)
Lancet Oncol.
, vol.16
, pp. e165-e172
-
-
Oser, M.G.1
Niederst, M.J.2
Sequist, L.V.3
Engelman, J.A.4
-
93
-
-
84924590266
-
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
-
Niederst, M.J. et al. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer. Nat. Commun. 6, 6377 (2015).
-
(2015)
Nat. Commun.
, vol.6
, pp. 6377
-
-
Niederst, M.J.1
-
94
-
-
79953118839
-
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
-
Sequist, L.V. et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci. Transl. Med. 3, 75ra26 (2011).
-
(2011)
Sci. Transl. Med.
, vol.3
, pp. 75ra26
-
-
Sequist, L.V.1
-
95
-
-
84875950992
-
Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease
-
Ohashi, K., Maruvka, Y.E., Michor, F. & Pao, W. Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease. J. Clin. Oncol. 31, 1070-1080 (2013).
-
(2013)
J. Clin. Oncol.
, vol.31
, pp. 1070-1080
-
-
Ohashi, K.1
Maruvka, Y.E.2
Michor, F.3
Pao, W.4
-
96
-
-
38049150665
-
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
-
Bean, J. et al. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc. Natl. Acad. Sci. USA 104, 20932-20937 (2007).
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 20932-20937
-
-
Bean, J.1
-
97
-
-
34249075147
-
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
-
Engelman, J.A. et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316, 1039-1043 (2007).
-
(2007)
Science
, vol.316
, pp. 1039-1043
-
-
Engelman, J.A.1
-
98
-
-
13844317894
-
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
-
Kobayashi, S. et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 352, 786-792 (2005).
-
(2005)
N. Engl. J. Med.
, vol.352
, pp. 786-792
-
-
Kobayashi, S.1
-
99
-
-
84900836746
-
Proposed morphologic classification of prostate cancer with neuroendocrine differentiation
-
Epstein, J.I. et al. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. Am. J. Surg. Pathol. 38, 756-767 (2014).
-
(2014)
Am. J. Surg. Pathol.
, vol.38
, pp. 756-767
-
-
Epstein, J.I.1
-
100
-
-
0028990077
-
Molecular genetic characterization of neuroendocrine lung cancer cell lines
-
Lai, S.L. et al. Molecular genetic characterization of neuroendocrine lung cancer cell lines. Anticancer Res. 15, 225-232 (1995).
-
(1995)
Anticancer Res.
, vol.15
, pp. 225-232
-
-
Lai, S.L.1
-
101
-
-
33947358183
-
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: A new perspective for an old model
-
Mertz, K.D. et al. Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. Neoplasia 9, 200-206 (2007).
-
(2007)
Neoplasia
, vol.9
, pp. 200-206
-
-
Mertz, K.D.1
-
102
-
-
0032846627
-
Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo
-
Burchardt, T. et al. Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J. Urol. 162, 1800-1805 (1999).
-
(1999)
J. Urol.
, vol.162
, pp. 1800-1805
-
-
Burchardt, T.1
-
103
-
-
0028356553
-
Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP
-
Bang, Y.J. et al. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc. Natl. Acad. Sci. USA 91, 5330-5334 (1994).
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 5330-5334
-
-
Bang, Y.J.1
-
104
-
-
0032584160
-
Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells
-
Qiu, Y., Robinson, D., Pretlow, T.G. & Kung, H.J. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc. Natl. Acad. Sci. USA 95, 3644-3649 (1998).
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 3644-3649
-
-
Qiu, Y.1
Robinson, D.2
Pretlow, T.G.3
Kung, H.J.4
-
105
-
-
57149095259
-
Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: Implications for disease progression
-
Deng, X. et al. Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression. Cancer Res. 68, 9663-9670 (2008).
-
(2008)
Cancer Res.
, vol.68
, pp. 9663-9670
-
-
Deng, X.1
-
106
-
-
84894275509
-
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development
-
Lin, D. et al. High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development. Cancer Res. 74, 1272-1283 (2014).
-
(2014)
Cancer Res.
, vol.74
, pp. 1272-1283
-
-
Lin, D.1
-
107
-
-
0036969388
-
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
-
True, L.D. et al. A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49. Am. J. Pathol. 161, 705-715 (2002).
-
(2002)
Am. J. Pathol.
, vol.161
, pp. 705-715
-
-
True, L.D.1
-
108
-
-
0023481234
-
Xenografted small cell undifferentiated cancer of prostate: Possible common origin with prostatic adenocarcinoma
-
van Haaften Day, C. et al. Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma. Prostate 11, 271-279 (1987).
-
(1987)
Prostate
, vol.11
, pp. 271-279
-
-
Van Haaften-Day, C.1
-
109
-
-
0034544604
-
WISH-PC2: A unique xenograft model of human prostatic small cell carcinoma
-
Pinthus, J.H. et al. WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma. Cancer Res. 60, 6563-6567 (2000).
-
(2000)
Cancer Res.
, vol.60
, pp. 6563-6567
-
-
Pinthus, J.H.1
-
110
-
-
84975685847
-
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
-
Lapuk, A.V. et al. From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer. J. Pathol. 227, 286-297 (2012).
-
(2012)
J. Pathol.
, vol.227
, pp. 286-297
-
-
Lapuk, A.V.1
-
111
-
-
84947045416
-
The placental gene PEG10 promotes progression of neuroendocrine prostate cancer
-
Akamatsu, S. et al. The placental gene PEG10 promotes progression of neuroendocrine prostate cancer. Cell Reports 12, 922-936 (2015).
-
(2015)
Cell Reports
, vol.12
, pp. 922-936
-
-
Akamatsu, S.1
-
112
-
-
79953701350
-
Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single Patient's tumor: Morphological, immunohistochemical, and gene expression profiles
-
Aparicio, A. et al. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles. Prostate 71, 846-856 (2011).
-
(2011)
Prostate
, vol.71
, pp. 846-856
-
-
Aparicio, A.1
-
113
-
-
0029781016
-
Neuroendocrine differentiation in human prostatic tumor models
-
Noordzij, M.A. et al. Neuroendocrine differentiation in human prostatic tumor models. Am. J. Pathol. 149, 859-871 (1996).
-
(1996)
Am. J. Pathol.
, vol.149
, pp. 859-871
-
-
Noordzij, M.A.1
-
114
-
-
2942565608
-
Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: Association with tumor cell proliferation prior to recurrence
-
Huss, W.J., Gregory, C.W. & Smith, G.J. Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: association with tumor cell proliferation prior to recurrence. Prostate 60, 91-97 (2004).
-
(2004)
Prostate
, vol.60
, pp. 91-97
-
-
Huss, W.J.1
Gregory, C.W.2
Smith, G.J.3
-
115
-
-
84862650290
-
Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway
-
Chen, H. et al. Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway. Endocr. Relat. Cancer 19, 321-331 (2012).
-
(2012)
Endocr. Relat. Cancer
, vol.19
, pp. 321-331
-
-
Chen, H.1
-
116
-
-
84920747084
-
Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis
-
Kareta, M.S. et al. Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis. Cell Stem Cell 16, 39-50 (2015).
-
(2015)
Cell Stem Cell
, vol.16
, pp. 39-50
-
-
Kareta, M.S.1
-
117
-
-
85009354343
-
The master neural transcription factor BRN2 is an androgen receptor-suppressed driver of neuroendocrine differentiation in prostate cancer
-
Bishop, J.L. et al. The master neural transcription factor BRN2 is an androgen receptor-suppressed driver of neuroendocrine differentiation in prostate cancer. Cancer Discov. 7, 54-71 (2017).
-
(2017)
Cancer Discov.
, vol.7
, pp. 54-71
-
-
Bishop, J.L.1
-
118
-
-
85020302825
-
Transdifferentiation as a mechanism of treatment resistance in a mouse model of castration-resistant prostate cancer
-
Zou, M. et al. Transdifferentiation as a mechanism of treatment resistance in a mouse model of castration-resistant prostate cancer. Cancer Discov. http://dx.doi.org/10.1158/2159-8290.CD-16-1174 (2017).
-
(2017)
Cancer Discov.
-
-
Zou, M.1
-
119
-
-
84863911486
-
Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: Results from a randomized, double-blind, multicenter phase II study
-
Lynch, T.J. et al. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J. Clin. Oncol. 30, 2046-2054 (2012).
-
(2012)
J. Clin. Oncol.
, vol.30
, pp. 2046-2054
-
-
Lynch, T.J.1
-
120
-
-
84976511909
-
PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma
-
Nghiem, P.T. et al. PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma. N. Engl. J. Med. 374, 2542-2552 (2016).
-
(2016)
N. Engl. J. Med.
, vol.374
, pp. 2542-2552
-
-
Nghiem, P.T.1
-
121
-
-
84895779578
-
Drugging the p53 pathway: Understanding the route to clinical efficacy
-
Khoo, K.H., Verma, C.S. & Lane, D.P. Drugging the p53 pathway: understanding the route to clinical efficacy. Nat. Rev. Drug Discov. 13, 217-236 (2014).
-
(2014)
Nat. Rev. Drug Discov.
, vol.13
, pp. 217-236
-
-
Khoo, K.H.1
Verma, C.S.2
Lane, D.P.3
-
122
-
-
85006386995
-
Targeting mutant p53 in cancer: A long road to precision therapy
-
Mantovani, F., Walerych, D. & Sal, G.D. Targeting mutant p53 in cancer: a long road to precision therapy. FEBS J. 284, 837-850 (2017).
-
(2017)
FEBS J.
, vol.284
, pp. 837-850
-
-
Mantovani, F.1
Walerych, D.2
Sal, G.D.3
-
123
-
-
84880042989
-
Small molecule inhibitors of aurora-A induce proteasomal degradation of N-myc in childhood neuroblastoma
-
Brockmann, M. et al. Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer Cell 24, 75-89 (2013).
-
(2013)
Cancer Cell
, vol.24
, pp. 75-89
-
-
Brockmann, M.1
-
124
-
-
84908689719
-
Drugging MYCN through an allosteric transition in aurora kinase A
-
Gustafson, W.C. et al. Drugging MYCN through an allosteric transition in Aurora kinase A. Cancer Cell 26, 414-427 (2014).
-
(2014)
Cancer Cell
, vol.26
, pp. 414-427
-
-
Gustafson, W.C.1
-
125
-
-
84859399268
-
An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735
-
Hook, K.E. et al. An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735. Mol. Cancer Ther. 11, 710-719 (2012).
-
(2012)
Mol. Cancer Ther.
, vol.11
, pp. 710-719
-
-
Hook, K.E.1
-
126
-
-
84978437311
-
Identification and targeting of long-term tumor-propagating cells in small cell lung cancer
-
Jahchan, N.S. et al. Identification and targeting of long-term tumor-propagating cells in small cell lung cancer. Cell Rep. 16, 644-656 (2016).
-
(2016)
Cell Rep.
, vol.16
, pp. 644-656
-
-
Jahchan, N.S.1
-
127
-
-
84875757638
-
Punctuated evolution of prostate cancer genomes
-
Baca, S.C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666-677 (2013).
-
(2013)
Cell
, vol.153
, pp. 666-677
-
-
Baca, S.C.1
-
128
-
-
84960194345
-
Genomic analyses identify molecular subtypes of pancreatic cancer
-
Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47-52 (2016).
-
(2016)
Nature
, vol.531
, pp. 47-52
-
-
Bailey, P.1
-
129
-
-
84861581164
-
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
-
Barbieri, C.E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689 (2012).
-
(2012)
Nat. Genet.
, vol.44
, pp. 685-689
-
-
Barbieri, C.E.1
-
130
-
-
84869091997
-
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
-
Biankin, A.V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399-405 (2012).
-
(2012)
Nature
, vol.491
, pp. 399-405
-
-
Biankin, A.V.1
-
131
-
-
84946195510
-
The molecular taxonomy of primary prostate cancer
-
Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell 163, 1011-1025 (2015).
-
(2015)
Cell
, vol.163
, pp. 1011-1025
-
-
-
132
-
-
84863723010
-
The mutational landscape of lethal castration-resistant prostate cancer
-
Grasso, C.S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239-243 (2012).
-
(2012)
Nature
, vol.487
, pp. 239-243
-
-
Grasso, C.S.1
-
133
-
-
84959255550
-
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
-
Kumar, A. et al. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat. Med. 22, 369-378 (2016).
-
(2016)
Nat. Med.
, vol.22
, pp. 369-378
-
-
Kumar, A.1
-
134
-
-
84866849548
-
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
-
Rudin, C.M. et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat. Genet. 44, 1111-1116 (2012).
-
(2012)
Nat. Genet.
, vol.44
, pp. 1111-1116
-
-
Rudin, C.M.1
-
135
-
-
77954255681
-
Integrative genomic profiling of human prostate cancer
-
Taylor, B.S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22 (2010).
-
(2010)
Cancer Cell
, vol.18
, pp. 11-22
-
-
Taylor, B.S.1
-
136
-
-
84897440556
-
The prenatal origins of cancer
-
Marshall, G.M. et al. The prenatal origins of cancer. Nat. Rev. Cancer 14, 277-289 (2014).
-
(2014)
Nat. Rev. Cancer
, vol.14
, pp. 277-289
-
-
Marshall, G.M.1
-
137
-
-
0022650216
-
Differential expression of myc family genes during murine development
-
Zimmerman, K.A. et al. Differential expression of myc family genes during murine development. Nature 319, 780-783 (1986).
-
(1986)
Nature
, vol.319
, pp. 780-783
-
-
Zimmerman, K.A.1
-
138
-
-
0034641936
-
Apoptosis in the nervous system
-
Yuan, J. & Yankner, B.A. Apoptosis in the nervous system. Nature 407, 802-809 (2000).
-
(2000)
Nature
, vol.407
, pp. 802-809
-
-
Yuan, J.1
Yankner, B.A.2
-
139
-
-
85009266752
-
Reprogramming to resist
-
Kelly, K. & Balk, S.P. Reprogramming to resist. Science 355, 29-30 (2017).
-
(2017)
Science
, vol.355
, pp. 29-30
-
-
Kelly, K.1
Balk, S.P.2
|